Yahoo Web Search

Search results

  1. An international nonproprietary name ( INN) is an official generic and nonproprietary name given to a pharmaceutical drug or an active ingredient. [2] INNs are intended to make communication more precise by providing a unique standard name for each active ingredient, to avoid prescribing errors. [1] The INN system has been coordinated by the ...

  2. International non-proprietary name. The globally recognised name used to identify the active ingredient in a medicine. Abbreviated as INN. For more information, see international non-proprietary names.

  3. People also ask

  4. Guidance. International Nonproprietary Names (INN) facilitate the identification of pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property. A nonproprietary name is also known as a generic name. General guidance.

  5. pharmaceutical ingredient by a unique name that is globally recognized and is public property. A nonproprietary name is also known as a generic name. The INN system as it exists today was initiated in 1950 by a World Health Assembly resolution WHA3.11 and began operating in 1953, when the first list of International Nonproprietary Names for

    • 702KB
    • 55
  6. More than 50 years ago, WHO established the International Nonproprietary Name (INN) Expert Group/WHO Expert Committee on Specifications for Pharmaceutical Preparations, to assign nonproprietary names (INN) to medicinal substances, so that each substance would be recognized globally by a unique name.

  7. Feb 4, 2021 · The WHO International Nonproprietary Names Programme would like to highlight that international non-proprietary names (INNs), assigned to well defined pharmaceutical substances, including those used in vaccines, ensure that each substance is recognised globally by a unique and distinct name. Traditional vaccines that are based on live-attenuated or inactivated pathogens are assigned short ...

  8. use of trade-marks that are derived from international nonproprietary names, 1. REQUESTS Member States: (1) to enact rules or regulations, as necessary, to ensure that international nonproprietary names (or the equivalent nationally approved generic names) used in the labelling and advertising of pharmaceutical products are always displayed

  1. People also search for